Infliximab

CHEBI:CHEBI_747852

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_strength
100 mg/10mL
nui
N0000175451
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
active_ingredient_name
INFLIXIMAB-ABDA
unii
B72HH48FLU
spl_set_id
dbf738c4-3fac-4422-a9d8-51d9c83a8789
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
generic_name
Infliximab 40.0 mg/mL Drug Substance
rxcui
1927290
product_type
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
route
INTRAVENOUS
marketing_start_date
19980824
marketing_category
BULK INGREDIENT
package_marketing_start_date
08-JUL-23
brand_name
Renflexis
brand_name_base
Renflexis
labeler_name
Samsung BioLogics Co. LTD
manufacturer_name
Janssen Biotech, Inc.
product_ndc
69438-0007
spl_id
1bdbe5fc-45d5-c64f-e063-6394a90a6f05
package_ndc
69438-0007-2
package_description
5000 mL in 1 BOTTLE (69438-0007-2)
application_number
BLA761054